Compare Wockhardt with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs NOVARTIS - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT NOVARTIS WOCKHARDT/
NOVARTIS
 
P/E (TTM) x -13.4 518.8 - View Chart
P/BV x 1.0 29.1 3.6% View Chart
Dividend Yield % 0.0 1.5 0.2%  

Financials

 WOCKHARDT   NOVARTIS
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
NOVARTIS
Mar-19
WOCKHARDT/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs1,012980 103.3%   
Low Rs532600 88.6%   
Sales per share (Unadj.) Rs355.9198.7 179.1%  
Earnings per share (Unadj.) Rs-60.321.0 -287.5%  
Cash flow per share (Unadj.) Rs-46.822.3 -210.1%  
Dividends per share (Unadj.) Rs0.0110.00 0.1%  
Dividend yield (eoy) %01.3 0.1%  
Book value per share (Unadj.) Rs257.8307.5 83.8%  
Shares outstanding (eoy) m110.6324.69 448.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.24.0 54.5%   
Avg P/E ratio x-12.837.7 -34.0%  
P/CF ratio (eoy) x-16.535.5 -46.5%  
Price / Book Value ratio x3.02.6 116.5%  
Dividend payout %047.7 -0.0%   
Avg Mkt Cap Rs m85,37919,508 437.7%   
No. of employees `0006.30.6 1,076.4%   
Total wages/salary Rs m9,3711,171 800.2%   
Avg. sales/employee Rs Th6,295.08,445.4 74.5%   
Avg. wages/employee Rs Th1,498.32,015.7 74.3%   
Avg. net profit/employee Rs Th-1,066.3891.0 -119.7%   
INCOME DATA
Net Sales Rs m39,3694,907 802.3%  
Other income Rs m1,202783 153.6%   
Total revenues Rs m40,5715,689 713.1%   
Gross profit Rs m18123 14.9%  
Depreciation Rs m1,49532 4,702.2%   
Interest Rs m2,55516 16,068.6%   
Profit before tax Rs m-2,830858 -329.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257340 75.6%   
Profit after tax Rs m-6,669518 -1,288.1%  
Gross profit margin %02.5 1.9%  
Effective tax rate %-9.139.6 -22.9%   
Net profit margin %-16.910.6 -160.5%  
BALANCE SHEET DATA
Current assets Rs m33,7968,055 419.6%   
Current liabilities Rs m26,9171,850 1,454.9%   
Net working cap to sales %17.5126.4 13.8%  
Current ratio x1.34.4 28.8%  
Inventory Days Days7945 176.3%  
Debtors Days Days8934 263.1%  
Net fixed assets Rs m39,664150 26,478.0%   
Share capital Rs m553123 448.3%   
"Free" reserves Rs m27,9687,469 374.5%   
Net worth Rs m28,5227,592 375.7%   
Long term debt Rs m21,7310-   
Total assets Rs m81,6209,824 830.8%  
Interest coverage x-0.154.9 -0.2%   
Debt to equity ratio x0.80-  
Sales to assets ratio x0.50.5 96.6%   
Return on assets %-5.05.4 -92.8%  
Return on equity %-23.46.8 -342.9%  
Return on capital %-7.711.5 -66.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,80758 17,026.2%   
Fx outflow Rs m1,7891,326 134.9%   
Net fx Rs m8,019-1,269 -632.0%   
CASH FLOW
From Operations Rs m684-1,943 -35.2%  
From Investments Rs m6,3022,742 229.8%  
From Financial Activity Rs m-7,695-298 2,580.4%  
Net Cashflow Rs m-664501 -132.5%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 2.3 2.0 115.0%  
FIIs % 7.7 1.6 481.3%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 21.5 71.6%  
Shareholders   67,757 41,647 162.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   SUN PHARMA  PROCTER & GAMBLE HEALTH  GSK PHARMA  FULFORD INDIA  DR. REDDYS LAB  

Compare WOCKHARDT With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Nov 15, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS